|
Caesar Rivise offers its pharmaceutical clients an exceptionally high level of litigation experience nationwide in today's quickly changing, complex and high stakes patent litigation environment, particularly in cases involving Paragraph IV patent challenges under the Hatch Waxman Act. The ANDA team's legal expertise and pharmaceutical industry know-how are hallmarks of Caesar Rivise. The firm counsels its clients on all related matters including product design and clearance, patent litigation strategies and at-risk launches.
|
